Paul Joseph Santerre

This inventor holds 38 USPTO granted patents and 21 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Biomedical Materials. Top assignees: Interface Biologics, Inc., Angiodynamics, Inc., University of Toronto. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Joseph Santerre. Retrieved from https://idiyas.com/inventor/paul-joseph-santerre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 21)

% Patents Active = 89.5

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 15)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 392(Granted Patents)

Location History:

Ontario, CA (1998)
Whitby, CA (1999 - 2021)
Toronto, CA (1999 - 2024)

Company Filing History:

12 out of 21

Interface Biologics, Inc.

University of Toronto

Ripple Therapeutics Corporation

patents

6. 2 out of 51

Sunnybrook Health Sciences Centre

patents

7. 1 out of 1

Fielding Chemicals Limited

patent

8. 1 out of 52

Mount Sinai Hospital Corporation

Sunnybrok Health Sciences Centre

patent

11. 1 out of 312

University Health Network

13. 4 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Biomedical Applications

Surface Modifying Macromolecules

Drug Delivery Systems

Soft Tissue Fillers

Bioactive Polymers

Thermoplastic Polyurethane

Fluoropolymer Additives

Bone Stabilization Devices

Fibrous Scaffolds

Dexamethasone Prodrugs

Inorganic Structures

Oligofluorinated Polymers

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325788 - Plasticized PVC admixtures with surface modifying macromolecules and articles made therefrom (2025-06-10),

2. 12239758 - Adhesive device for biomedical applications and methods of use thereof (2025-03-04),

3. 11976163 - Carbonate-linked surface modifying macromolecules (2024-05-07),

4. 10975197 - Ester-linked surface modifying macromolecules (2021-04-13),

5. 10973950 - Biomaterial with reduced inflammatory response (2021-04-13),

6. 10959954 - Dexamethasone prodrug compositions and uses thereof (2021-03-30),

7. 10945958 - Dexamethasone prodrug compositions and uses thereof (2021-03-16),

8. 10772992 - Soft tissue filler (2020-09-15),

9. 10646264 - Bone stabilization device and method of production (2020-05-12),

10. 10632075 - Glass formulations and uses thereof (2020-04-28),

11. 10588862 - Dexamethasone prodrug compositions and uses thereof (2020-03-17),

12. 10557030 - Plasticized PVC admixtures with surface modifying macromolecules and articles made therefrom (2020-02-11),

13. 10195311 - Local delivery of drugs from self assembled coatings (2019-02-05),

14. 10195044 - Intervertebral disc implant (2019-02-05),

15. 10045801 - Bone stabilization device and method of production (2018-08-14),

Title: Revolutionizing Dental and Medical Fields: The Innovations of Inventor Paul Joseph Santerre

Introduction:

Paul Joseph Santerre, a renowned inventor hailing from Whitby, Canada, has made remarkable contributions to the fields of dentistry and medicine. With a keen focus on developing cutting-edge tissue infiltrating primer formulations, his work stands at the forefront of innovation.

Latest Patents:

Santerre's groundbreaking patent titled "Dental and medical primer formulations containing tissue infiltrating" introduces revolutionary methods for enhancing the penetration of biomaterials into target substrates, particularly hard tissues. This patent showcases his inventive genius and commitment to advancing healthcare technologies.

Career Highlights:

Currently affiliated with the prestigious University of Toronto Innovations Foundation, Santerre leverages his expertise to drive forward novel research and development endeavors. His dedication to pushing the boundaries of science and technology is evident in the transformative impact of his inventions within the dental and medical sectors.

Collaborations:

Throughout his illustrious career, Santerre has collaborated closely with esteemed professionals such as Keith Titley and Robert Chernecky. Together, they have synergized their diverse skill sets to bring forth innovative solutions that address critical challenges in healthcare delivery and patient treatment.

Conclusion:

Inventor Paul Joseph Santerre's unwavering commitment to innovation and his pioneering spirit have cemented his standing as a trailblazer in the realms of dentistry and medicine. His patented technologies not only reflect his technical acumen but also underscore his profound impact on shaping the future of healthcare practices.

Profile summary based on public USPTO records.